Detalhe da pesquisa
1.
Integrative Review of Managed Entry Agreements: Chances and Limitations.
Pharmacoeconomics
; 38(11): 1165-1185, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32734573
2.
Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets.
Front Public Health
; 6: 328, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30568938
3.
The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications.
Pharmacoeconomics
; 35(12): 1271-1285, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28836222